Log in to save to my catalogue

Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson’s disease patien...

Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson’s disease patien...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2599308d336c480396370313c6255b52

Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson’s disease patients treated with subthalamic stimulation

About this item

Full title

Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson’s disease patients treated with subthalamic stimulation

Publisher

London: Nature Publishing Group UK

Journal title

NPJ Parkinson's Disease, 2024-10, Vol.10 (1), p.197-6, Article 197

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The ability of serum biomarkers to predict the prognosis and response to deep-brain stimulation (DBS) therapy in Parkinson’s disease (PD) patients is promising. Here, we showed that NfL differed between healthy individuals and PD patients and that changes in NfL, GFAP, and BDNF occurred only transiently after DBS surgery. Therefore, subthalamic sti...

Alternative Titles

Full title

Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson’s disease patients treated with subthalamic stimulation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2599308d336c480396370313c6255b52

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2599308d336c480396370313c6255b52

Other Identifiers

ISSN

2373-8057

E-ISSN

2373-8057

DOI

10.1038/s41531-024-00808-w

How to access this item